Integrated Cancer Repository for Cancer Research

Conditions

• Anal Cancer
• Bile Duct Cancer
• Bladder Cancer
• Breast Cancer
• Central Nervous System Cancer
• Central Nervous System Tumor
• Colon Cancer
• Duodenal Cancer
• Endometrial Cancer
• Esophageal Cancer
• Familial Adenomatous Polyposis
• Gallbladder Cancer
• Gastric Cancer
• Gastrointestinal Stromal Tumors
• Healthy Control
• Hypopharyngeal Cancer
• Kidney Cancer
• Laryngeal Cancer
• Leukemia
• Lip Cancer
• Liver Cancer
• Lung Cancer
• Lynch Syndrome
• Melanoma
• Mesothelioma
• Multiple Myeloma
• Nasal Cavity Cancer
• Nasopharyngeal Cancer
• Neuroendocrine Tumors
• Oral Cavity Cancer
• Oropharyngeal Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Paranasal Sinus Cancer
• Penile Cancer
• Peritoneal Surface Malignancies
• Plasma Cell Dyscrasia
• Prostate Cancer
• Rectal Cancer
• Salivary Gland Cancer
• Sarcoma
• Skin Cancer
• Small Intestine Cancer
• Testicular Cancer
• Thymus Cancer
• Thyroid Cancer
• Unknown Primary Tumor
• Ureter Cancer
• Urethral Cancer
• Vaginal Cancer

Eligibility Criteria

Sex

ALL

Age

19 Years - 110 Years

Healthy Volunteers

Accepted

Study Details

The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, high-risk individuals, and normal controls. The distinct characteristic of the iCaRe2 is its geographical coverage, with a significant percentage of small and rural hospitals and cancer centers. The iCaRe2 advances comprehensive studies of risk factors of cancer development and progression and enables the design of novel strategies for prevention, screening, early detection and personalized treatment of cancer. Centers with expertise in cancer epidemiology, genetics, biology, early detection, and patient care can collaborate by using the iCaRe2 as a platform for cohort and population studies.

Key Dates

Start date

Nov 1, 2013

Status verified

Jun 2025

Primary completion

Dec 31, 2099

Completion

Dec 31, 2099

Study Design

Enrollment

999,999 participants (estimated)

Primary Outcome Measure

Development and Implementation of a Web-based Cancer Collaborative Registry [ Time Frame: 86 years ]

Central Contacts

• Kurt Fisher, MD, PhD
  402-559-9025
  [email protected]

Locations (42)

Find similar trials in Greenwood Village, CO

Related Studies

• Studies on Tumors of the Thyroid
  Recruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
• Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
  Recruiting · National Cancer Institute (NCI) · Bethesda, Maryland
• Evaluation for NCI Surgery Branch Clinical Research Protocols
  Recruiting · National Cancer Institute (NCI) · Bethesda, Maryland
• Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
  Recruiting · Northwestern University · Chicago, Illinois